HLB Co. Ltd (028300) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.036x

Based on the latest financial reports, HLB Co. Ltd (028300) has a cash flow conversion efficiency ratio of -0.036x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-17.75 Billion ≈ $-12.03 Million USD) by net assets (₩493.87 Billion ≈ $334.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HLB Co. Ltd net asset quality index to measure how much of total assets are equity-financed.

HLB Co. Ltd - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how HLB Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 028300 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

HLB Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HLB Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Siriuspoint Ltd NYSE:SPNT	-0.012x
ACC Limited NSE:ACC	-0.111x
Shenzhen Gas Corp Ltd SHG:601139	0.053x
Uxi Unicomp Technology Co. Ltd. A SHG:688531	N/A
Vapores SN:VAPORES	-0.073x
Sumitomo Chemical India Limited NSE:SUMICHEM	0.136x
CarGurus NASDAQ:CARG	0.295x
Kangmei Pharmaceutical Co Ltd SHG:600518	0.030x

Annual Cash Flow Conversion Efficiency for HLB Co. Ltd (2010–2025)

The table below shows the annual cash flow conversion efficiency of HLB Co. Ltd from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see market value of HLB Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩494.41 Billion ≈ $335.06 Million	₩-92.59 Billion ≈ $-62.75 Million	-0.187x	+5.55%
2024-12-31	₩576.57 Billion ≈ $390.73 Million	₩-114.31 Billion ≈ $-77.47 Million	-0.198x	-3.41%
2023-12-31	₩582.25 Billion ≈ $394.58 Million	₩-111.63 Billion ≈ $-75.65 Million	-0.192x	-97.86%
2022-12-31	₩637.94 Billion ≈ $432.32 Million	₩-61.82 Billion ≈ $-41.89 Million	-0.097x	+22.86%
2021-12-31	₩435.96 Billion ≈ $295.44 Million	₩-54.77 Billion ≈ $-37.11 Million	-0.126x	-6.64%
2020-12-31	₩479.75 Billion ≈ $325.12 Million	₩-56.51 Billion ≈ $-38.30 Million	-0.118x	+55.24%
2019-12-31	₩184.89 Billion ≈ $125.30 Million	₩-48.66 Billion ≈ $-32.97 Million	-0.263x	-57.63%
2018-12-31	₩174.68 Billion ≈ $118.38 Million	₩-29.16 Billion ≈ $-19.76 Million	-0.167x	+32.42%
2017-12-31	₩77.24 Billion ≈ $52.35 Million	₩-19.08 Billion ≈ $-12.93 Million	-0.247x	-115.97%
2016-12-31	₩88.75 Billion ≈ $60.14 Million	₩-10.15 Billion ≈ $-6.88 Million	-0.114x	-1436.44%
2015-12-31	₩84.65 Billion ≈ $57.37 Million	₩724.49 Million ≈ $490.97K	0.009x	+104.96%
2014-12-31	₩23.02 Billion ≈ $15.60 Million	₩-3.97 Billion ≈ $-2.69 Million	-0.173x	-601.71%
2011-12-31	₩21.19 Billion ≈ $14.36 Million	₩728.78 Million ≈ $493.89K	0.034x	+164.06%
2010-12-31	₩23.31 Billion ≈ $15.79 Million	₩303.53 Million ≈ $205.70K	0.013x	--

About HLB Co. Ltd

KQ:028300 Korea Biotechnology

Market Cap

$2.76 Billion

₩4.07 Trillion KRW

Market Cap Rank

#5087 Global

#110 in Korea

Share Price

₩30600.00

Change (1 day)

+2.17%

52-Week Range

₩25650.00 - ₩68200.00

All Time High

₩120800.00